This inventor holds 1 USPTO granted patent. Top assignee: Pangen Biotech Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Jeong Do Kim in Biotechnology
Introduction
Jeong Do Kim is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for animal cells. His work has implications for the efficient expression of recombinant proteins, which is crucial in various biotechnological applications.
Latest Patents
One of Jeong Do Kim's key patents is titled "Expression vector for animal cell containing nuclear matrix attachment region of interferon beta." This invention relates to mammalian expression vectors that include the nuclear matrix attachment region of human interferon beta. Specifically, it involves pPGM-1, pPGM-2, and pPGM-3, which incorporate the nuclear matrix attachment region of the interferon beta gene. These expression vectors are designed to confer position-independent expression of the introduced foreign gene, thereby increasing the frequency of colonies that efficiently express the recombinant protein.
Career Highlights
Jeong Do Kim is currently associated with Pangen Biotech Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the understanding and application of expression vectors in mammalian systems.
Collaborations
Throughout his career, Jeong Do Kim has collaborated with several talented individuals, including Hye-Yeon Hwang and Dong-jun Kim. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Jeong Do Kim's contributions to biotechnology, particularly through his innovative patents, highlight his role as a significant inventor in the field. His work continues to influence the development of effective biotechnological solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile